Indication

Multicenter Study

1 clinical trial

1 product

Clinical trial

Multicentre Clinical Trial of the Efficacy and Safety of Tislelizumab in Combination With BCG Bladder Instillation in the Prevention of Postoperative Recurrence in Intermediate and High-risk Non-muscle Invasive Bladder Cancer

Status: Recruiting, Estimated PCD: 2025-06-01

Product